Due to the growing consumer awareness of the benefits of L-carnitine supplementation, the industry is anticipated to experience substantial growth during the forecast period. The food and pharmaceutical grade segment recorded the highest market share in 2018 and in the years to come, is projected to witness significant growth. In addition, it is estimated that the increased use of L-carnitine and its animal feed derivatives will fuel market growth over the forecast period.
The Healthcare Product market dominated the Global L-Carnitine Market by Application in 2018, growing at a CAGR of 3.9 % during the forecast period. The Functional Drink market is experiencing a CAGR of 4% during (2019-2025).
The Chemical Synthesis market dominated the Global L-Carnitine Market by Process in 2018, growing at a CAGR of 4.2 % during the forecast period. The Bioprocess market is anticipated to witness a CAGR of 5.1% during (2019-2025).
The North America market dominated the Global L-Carnitine Market by Region in 2018. The Europe market is expected to witness a CAGR of 3.9% during (2019-2025). Additionally, The Asia Pacific market is poised to witness highest CAGR of 5.4% during (2019-2025).
Structural Insights: https://www.kbvresearch.com/l-carnitine-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Merck Group, Lonza Group AG, Northeast Pharmaceutical Group Co. Ltd., Cayman Chemical Company, Inc., Tokyo Chemical Industry Co. Ltd., Ceva Sante Animale S.A., Kaiyuan Hengtai Chemical Co., Ltd., ChengDa Pharmaceuticals Co., Ltd., HuangGang HuaYang Pharmaceutical Co., Ltd., and HuBei YuanCheng SaiChuang Technology Co. Ltd.
According to a new report Global L-Carnitine Market, published by KBV Research, The Global L-Carnitine Market size is expected to reach $219.2 Million by 2025, rising at a market growth of 4.56% CAGR during the forecast period.
Recent Strategies Deployed in L-Carnitine Market
» Partnerships, Collaborations and Agreements:
Feb-2019: Lonza Consumer Health & Nutrition collaborated with DuPont Nutrition & Health for manufacturing and supplying human milk oligosaccharide (HMO). The collaboration is based upon meeting the demand of infant nutrition sector; Lonza already provides a portfolio of health ingredients for infant nutrition such as Carnipure, a product inclusive of amino acid L-Carnitine.
» Product Launches and Product Expansions:
Oct-2019: Lonza launched new innovative MuscleGuard™ formulation, a unique patent pending ingredient combination comprising a clinically studied ratio of four nutrients such as Lonza’s Carnipure®L-Carnitine, Creatine and Leucine with vitamin D. The solution delivers positive results for recovery and sports performance through increases in muscle strength, activity, and mass.
Apr-2019: Merck introduced BioContinuum buffer delivery platform, a new building block in the BioContinuum Platform for next-generation bioprocessing. The platform offers contiGuous bioprocessing and it is an integrated solution for more efficient buffer delivery and it provides highest level of accuracy and precision in buffer preparation.
Nov-2018: Merck released BioContinuum™ Platform for the advancement of biotherapeutic drug manufacturing through simplified operations, improved efficiency, and greater quality & consistency.
» Acquisition and Mergers:
Jul-2019: Lonza took over sterile fill and finish facility from Novartis AG, based in Stein (CH). The acquisition helps Lonza Biotech and Pharma's present parental drug offerings based out of Basel (CH).
May-2019: Ceva signed an agreement to acquire IDT Biologika GmbH's veterinary biopharmaceutical portfolio. Under the acquisition, IDT will manufacture the human biotechnology vaccines and pharmaceuticals for international and national markets. The acquisition helps Ceva in strengthening its biological innovation and development.
Global L-Carnitine Market Segmentation
Food & Pharma Grade
Rest of North America
Rest of Europe
Rest of Asia Pacific
Rest of LAMEA
Lonza Group AG
Northeast Pharmaceutical Group Co. Ltd.
Cayman Chemical Company, Inc.
Tokyo Chemical Industry Co. Ltd.
Ceva Sante Animale S.A.
Kaiyuan Hengtai Chemical Co., Ltd.
ChengDa Pharmaceuticals Co., Ltd.
HuangGang HuaYang Pharmaceutical Co., Ltd.
HuBei YuanCheng SaiChuang Technology Co. Ltd.
L-Carnitine Market Related Reports:
Knowledge Based Value (KBV) Research is a global brand and consulting firm serving all kinds of business verticals, government and non-governmental organizations, and not-for-profit organizations. Our motto is to extend our services that will have a lasting impact on our clients who trust us with their business goals.
KBV Research provides syndicated market research and publishes more than 1200 Reports and Press Release covering a pool of vertical industries, including international, regional as well as country-level markets each year. Our reports are highly exhaustive in research scope and market coverage.
Over the years, Market research has been an important component of strategic decision making processes. Market research activities have been facilitating the search for new market opportunities, understanding the market gap, bringing in the key insights into the R & D departments, value addition to marketing and promotional functions and many more. In short, one can say that the market research has been a fog light to various industries, especially while taking strategic decisions.
PANACEA FOR RESEARCH
Our aim is to transform and customize our services to address the fast changing business needs of our clients. With innovative methods, we seek to empower our research tools with new capabilities that would eventually bring about customer delight, as we understand that businesses evolve.
KBV Research Reports